HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer’s disease
2016 · Scientific Reports · 149 citations
https://doi.org/10.1038/srep31895
H
Hidenori Homma
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
1.2K
Citations
15
h-index
21
i10-index
Hidenori Homma is an academic researcher from Tokyo Medical and Dental University. The author has contributed to research in topics: Genetic Neurodegenerative Diseases & Alzheimer's disease research and treatments & RNA Research and Splicing. The author has an h-index of 15, co-authored 35 publications.
ORCID: 0000-0003-3175-7463Papers by this author
worksYAP-dependent necrosis occurs in early stages of Alzheimer’s disease and regulates mouse model pathology
2020 · Nature Communications · 110 citations
https://doi.org/10.1038/s41467-020-14353-6
Fasting activates macroautophagy in neurons of Alzheimer’s disease mouse model but is insufficient to degrade amyloid-beta
2015 · Scientific Reports · 79 citations
https://doi.org/10.1038/srep12115
The intellectual disability gene PQBP1 rescues Alzheimer’s disease pathology
2018 · Molecular Psychiatry · 73 citations
https://doi.org/10.1038/s41380-018-0253-8
In utero gene therapy rescues microcephaly caused by Pqbp1-hypofunction in neural stem progenitor cells
2014 · Molecular Psychiatry · 42 citations
https://doi.org/10.1038/mp.2014.69
Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology
2018 · Nature Communications · 32 citations
https://doi.org/10.1038/s41467-018-02821-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat